Torrent Pharma Gains on Citi Upgrade

  Published 10 months ago

Torrent Pharmaceuticals' stock price is rising after Citigroup increased its price target to ₹4,000 per share. This upgrade follows the company's recently announced Q4FY25 financial results, signaling positive analyst sentiment.

  • Citi raised Torrent Pharma's price target.
  • Upgrade driven by Q4FY25 results.
  • Stock is currently trading higher.

You might like these

Sobha Slips Despite Q1 Profit Rise

J&K Connectivity Boost: ₹46,000 Crore Investment

India Eyes Energy Independence

Blue Jet Falls 10% After Q1 Miss

Indian Stocks Rally on Trade Relief & RBI Boost

Indraprastha Gas Rises Despite Profit Dip

JK Tyre: Q4 FY25 & FY25 Performance

News that matters the most ⚡